Novosti
Khirurgii

 This journal is
indexed in Scopus
journal cover
android icon Android Applicaion

Year 2020 Vol. 28 No 6

EXTREME MEDICINE

I.A. ARSENOVA 1, I.O. POHODENKO-CHUDAKOVA 2, M.A. LAR’KINA 3

TRIGGER POINT INJECTION THERAPY IN THE MANAGEMENT OF MYOFASCIAL PAIN SYNDROME IN THE MAXILLOFACIAL AREA

Center for Advanced Training of Medical Specialists 1, Novosibirsk,
Belarusian State Medical University 2, Minsk,
The Republic of Belarus;
Dental Clinic "Dentaliya-Blesk 3, Novosibirsk,
The Russian Federation

Objective. To evaluate the effectiveness of the trigger points injections in the treatment of myofascial pain syndrome in the maxillofacial area.
Methods. During the period of 2014-2017 the patients (n=124) with the myofascial pain syndrome (76 women and 48 men, aged 19 to 62 yrs.) have been treated. In addition to clinical and radiological diagnostic methods, all patients underwent electromyography; the pain intensity assessed according to the Visual Analogue Pain Scale (VAS). In order to relieve myofascial pain syndrome, the methods of traditional therapy such as splint therapy, occlusion correction, drug and physiotherapy were used. In the case if traditional methods were ineffective the injections of «Lymphomyosot» and «Traumel S» solutions into trigger points were performed according to the method of J. Kersschot (2010). Control examinations were carried out 1, 3, 6, 12 and 18 and 24 months after the manipulation. During the follow-up examinations, attention was paid to the complaints of patients; the pain intensity was assessed by VAS. The criteria for the positive results of treatment were considered to be the absence of pain in resting-state and during functioning.
Results. In case of conventional treatment, positive results were obtained in 86 out of 124 patients (69.4%). Trigger point injections performed due to insufficient treatment efficacy in 38 patients resulted in pain relief in 32 (84.2%). As shown by our observations, a long painless period (within two years) was observed in 12 (37.6%) patients. A long-term effect for a period up to one and a half years was fixed in 8 patients (25%), up to 1 year - in 7 patients (21.8%), up to 6 months – in 5 (15.6%).
Conclusion. Trigger-point injection has been shown to be one of the most effective treatment modalities to inactivate trigger points, provide prompt relief of symptoms and a long period of remission.

Keywords: myofascial pain syndrome; temporomandibular joint; trigger points; trigger point injections; electromyography; bruxism, psychoemotional stress
p. 694-701 of the original issue
References
  1. Fokina NM Litsevaia bol’. Chastnye aspekty. Lechenie. Consilium Medicum. 2017;19(9):44-48. (In Russ.)
  2. Gusev EI. Nevrologiia: nats ruk. Moscow: GEOTAR-Media, RF; 2019. T. 1. 880 p. https://www.neurology.ru/monografii-rukovodstva-i-metodicheskie-rekomendacii-monografii-uchebniki-uchebnye-posobiya-8 (In Russ.)
  3. Barbero M, Schneebeli A, Koetsier E, Maino P. Myofascial pain syndrome and trigger points: evaluation and treatment in patients with musculoskeletal pain. Curr Opin Support Palliat Care. 2019 Sep;13(3):270-76. doi: 10.1097/SPC.0000000000000445
  4. Mukhametova ER, Militskova AD, Baltina TV. Postural stability in patients with latent trigger zones of neck musculature Ul’ian Med-Biol Zhurn. 2019;(4):114-23. doi: 10.34014/2227-1848-2019-4-114-123 (In Russ.)
  5. Van Deun L, de Witte M, Goessens T, Halewyck S, Ketelaer MC, Matic M, Moens M, Vaes P, Van Lint M, Versijpt J. Facial pain: a comprehensive review and proposal for a pragmatic diagnostic approach. Eur Neurol. 2020;83(1):5-16. doi: 10.1159/000505727
  6. Kotsiubinskaya JV, Mikhailov VA, Mazo GE, Ashnokova IA. Myofascial pain syndrome in the dysfunction of the temporomandibular joint. Zhurn Nevrologii i Psikhiatrii im SS Korsakova. 2019;119(11):21-26. doi: 10.17116/jnevro201911911121 (In Russ.)
  7. Qin QG, Fu Y, Shi J, Wu Q, Wang SY, Cao QA, Feng SF, Cui X, Gao XY, Zhu B. Myofascial trigger point: an indicator of acupoint sensitization. Zhen Ci Yan Jiu. 2020 Jan 25;45(1):57-61. doi: 10.13702/j.1000-0607.1906906
  8. Eliassen M, Hjortsjö C, Olsen-Bergem H, Bjørnland T. Self-exercise programmes and occlusal splints in the treatment of TMD-related myalgia-Evidence-based medicine? J Oral Rehabil. 2019;46(11):1088-94. doi: 10.1111/joor.12856
  9. Kersschot J. The Clinical Guide to Biopuncture. The use of biotherapeutic injections in everyday practice. Inspiration, Aartstelaar, Belgium, 2010. 264 ð.
  10. Shavlovskaya OA, Fokina NM. Therapy of myofascial pain syndrome face with thioctic acid. Zhurn Nevrologii i Psikhiatrii im SS Korsakova. 2018;118(4):121-25. doi: 10.17116/jnevro201811841121-125 (In Russ.)
  11. Nouged E, Dajani J, Ku B, Al-Eryani K, Padilla M, Enciso R. Local anesthetic injections for the short-term treatment of head and neck myofascial pain syndrome: a systematic review with meta-analysis. J Oral Facial Pain Headache. 2019;33(2):183-98. doi: 10.11607/ofph.2277
  12. Fedotov SN, Gerasimova MA., Shorokhov SD, Tischenko AI. Botulinus toxin in complex treatment of myofacial pain syndrome. Stomatologiia. 2017;96(4):23-27. doi: 10.17116/stomat201796423-27 (In Russ.)
  13. Ilyin AA, Fazylova TA, Demchinsky EA., Olesova VN., Olesov EE. A complex treatment of irreducible displacement of the temporomandibular joint disc and myofascial pain disorders with the use of botulinum toxin. Klin Praktika. 2019;10(2):14-20. doi: 10.17816/clinpract10214-20 (In Russ.)
  14. Aksu Ö, Pekin Doğan Y, Say?ner Çağlar N, Şener BM. Comparison of the efficacy of dry needling and trigger point injections with exercise in temporomandibular myofascial pain treatment. Turk J Phys Med Rehabil. 2019 Sep;65(3):228-35. doi: 10.5606/tftrd.2019.1802
  15. Okada-Ogawa A, Sekine N, Watanabe K, Kohashi R, Asano S, Iwata K, Imamura Y. Change in muscle hardness after trigger point injection and physiotherapy for myofascial painsyndrome. J Oral Sci. 2019 Mar 28;61(1):36-44. doi: 10.2334/josnusd.17-0453
  16. Ahmed S, Subramaniam S, Sidhu K, Khattab S, Singh D, Babineau J, Kumbhare DA. Effect of local anesthetic versus botulinum toxin-A injections for myofascial pain disorders : a systematic review and meta-analysis. Clin J Pain. 2019 Apr;35(4):353-67. doi: 10.1097/AJP.0000000000000681
Address for correspondence:
220116, Republic of Belarus,
Minsk, Dzerzhinskii Av., 83,
Belarusian State Medical University,
the Surgical Dentistry Department
tel. +375296440720,
e-mail: ip-c@yandex.ru
Pohodenko-Chudakova Irina Olegovna
Information about the authors:
Arsenova Irina A., MD, Professor, Director of LLC “Center for Advanced Training of Medical Specialists”, Novosibirsk, Russian Federation.
http://orcid.org/0000-0002-7560-5050
Pohodenko-Chudakova Irina O., MD, Professor, Head of the Surgical Dentistry Department, Belarusian State Medical University, Minsk, Republic of Belarus.
http://orcid.org/0000-0002-0353-0125
Lar’kina Maria A., Director of LLC, Dental Clinic «Dentaliya-Blesk», Novosibirsk, Russian Federation
http://orcid.org/0000-0002-1452-0221
Contacts | ©Vitebsk State Medical University, 2007-2023